clopidogrel has been researched along with Adenocarcinoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baiwir, D; Bouznad, N; Delierneux, C; Delvenne, P; Dibato Epoh, J; Lancellotti, P; Mazzucchelli, G; Oury, C; Rahmouni, S; Servais, L; Wéra, O | 1 |
| Bergmeier, W; Boulaftali, Y; Cooley, BC; Dee, R; Fuentes, R; Geddings, JE; Getz, TM; Hisada, Y; Key, NS; Mackman, N; Whelihan, M; Wolberg, AS | 1 |
| Choe, KS; Jani, AB; Liauw, SL | 1 |
| Dellon, ES; Scholl, S; Shaheen, NJ | 1 |
| Greenspan, NR | 1 |
| Carroll, PR; Chan, JM; Choe, KS; Cowan, JE; D'Amico, AV; Liauw, SL | 1 |
| Arzur, J; Bessodes, A; Coquerel, A; De la Gastine, B | 1 |
7 other study(ies) available for clopidogrel and Adenocarcinoma
| Article | Year |
|---|---|
Platelets contribute to the initiation of colitis-associated cancer by promoting immunosuppression.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Blood Platelets; CD8-Positive T-Lymphocytes; Cells, Cultured; Clopidogrel; Colitis; Colon; Colorectal Neoplasms; Disease Models, Animal; Immune Tolerance; Lymphocytes, Tumor-Infiltrating; Male; Mice, Inbred C57BL; Myeloid Cells; Phenotype; Platelet Activation; Platelet Aggregation Inhibitors; Serum Amyloid A Protein; Tumor Escape | 2018 |
Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice.
Topics: Adenocarcinoma; Animals; Blood Platelets; Cell Line, Tumor; Cell-Derived Microparticles; Clopidogrel; Female; Flow Cytometry; Humans; Mice; Mice, Inbred C57BL; Neoplasms; Pancreatic Neoplasms; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Embolism; Thrombin; Thromboplastin; Thrombosis; Ticlopidine | 2016 |
External beam radiotherapy for prostate cancer patients on anticoagulation therapy: how significant is the bleeding toxicity?
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Anticoagulants; Clopidogrel; Follow-Up Studies; Hemorrhage; Humans; Male; Middle Aged; Multivariate Analysis; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Rectum; Severity of Illness Index; Ticlopidine; Transurethral Resection of Prostate; Urologic Diseases; Warfarin | 2010 |
Treatment of GERD and proton pump inhibitor use in the elderly: practical approaches and frequently asked questions.
Topics: Adenocarcinoma; Adult; Age Distribution; Age Factors; Aged; Aged, 80 and over; Aspirin; Barrett Esophagus; Clopidogrel; Drug Interactions; Drug Prescriptions; Esophageal Neoplasms; Esophagitis; Esophagoscopy; Gastroesophageal Reflux; Gastroscopy; Heartburn; Hip Fractures; Humans; Intestinal Absorption; Middle Aged; Obesity; Odds Ratio; Platelet Aggregation Inhibitors; Population Surveillance; Prevalence; Proton Pump Inhibitors; Ticlopidine; Vitamin B 12 | 2011 |
Gastroesophageal reflux disease: endoscopy, duration of treatment, and choice of PPI.
Topics: Adenocarcinoma; Clopidogrel; Drug Industry; Drug Interactions; Endoscopy, Gastrointestinal; Esophageal Neoplasms; Gastroesophageal Reflux; Humans; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Research Support as Topic; Ticlopidine | 2011 |
Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Chemoprevention; Clopidogrel; Enoxaparin; Humans; Male; Middle Aged; Prostatectomy; Prostatic Neoplasms; Risk; Ticlopidine; Warfarin | 2012 |
[Drugs induced Parkinsonism: the case of a 77 year old woman].
Topics: Acetaminophen; Adenocarcinoma; Aged; Antineoplastic Agents; Clopidogrel; Female; Humans; Hypertension; Parkinsonian Disorders; Ticlopidine | 2006 |